Pneumococcal immunization in immunocompromised hosts: where do we stand?
about
Pneumococcal Vaccination Strategies. An Update and Perspective.Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.PCVs in individuals at increased risk of pneumococcal disease: a literature review.Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients.Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program.Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.
P2860
Q33772409-B50C56CD-361F-475E-9BC4-6947B4A08485Q34452479-C0164322-F563-4405-A16E-B48E9BBA2EBFQ38530267-E24E602C-C8AA-4806-B114-3C3E1808FAC9Q38684316-BA7F44FB-E655-4560-A20C-A9E5005984CBQ40513544-A2A6F4BB-61D1-415D-B673-9581641D5C2CQ40663139-B4035DDB-4257-4929-9CAD-6E3EAB578F44Q41987062-0D31B81B-4A12-4C57-AD03-6BB408F4FF84
P2860
Pneumococcal immunization in immunocompromised hosts: where do we stand?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pneumococcal immunization in immunocompromised hosts: where do we stand?
@en
type
label
Pneumococcal immunization in immunocompromised hosts: where do we stand?
@en
prefLabel
Pneumococcal immunization in immunocompromised hosts: where do we stand?
@en
P2093
P2860
P1476
Pneumococcal immunization in immunocompromised hosts: where do we stand?
@en
P2093
Catherine Cordonnier
Dan Engelhard
Diana Averbuch
Sébastien Maury
P2860
P356
10.1586/14760584.2014.859990
P577
2013-12-04T00:00:00Z